| 000 | 01719 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250514162931.0 | ||
| 264 | 0 | _c20040325 | |
| 008 | 200403s 0 0 eng d | ||
| 022 | _a0885-3185 | ||
| 024 | 7 |
_a10.1002/mds.10542 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHill, Michael P | |
| 245 | 0 | 0 |
_aNovel antiepileptic drug levetiracetam decreases dyskinesia elicited by L-dopa and ropinirole in the MPTP-lesioned marmoset. _h[electronic resource] |
| 260 |
_bMovement disorders : official journal of the Movement Disorder Society _cNov 2003 |
||
| 300 |
_a1301-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_a1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine _xadverse effects |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnticonvulsants _xpharmacology |
| 650 | 0 | 4 |
_aAntiparkinson Agents _xadverse effects |
| 650 | 0 | 4 | _aCallithrix |
| 650 | 0 | 4 |
_aDopamine Agents _xadverse effects |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aIndoles _xadverse effects |
| 650 | 0 | 4 | _aLevetiracetam |
| 650 | 0 | 4 |
_aLevodopa _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aParkinsonian Disorders _xchemically induced |
| 650 | 0 | 4 |
_aPiracetam _xanalogs & derivatives |
| 700 | 1 | _aBezard, Erwan | |
| 700 | 1 | _aMcGuire, Steven G | |
| 700 | 1 | _aCrossman, Alan R | |
| 700 | 1 | _aBrotchie, Jonathan M | |
| 700 | 1 | _aMichel, Ann | |
| 700 | 1 | _aGrimée, Renee | |
| 700 | 1 | _aKlitgaard, Henrik | |
| 773 | 0 |
_tMovement disorders : official journal of the Movement Disorder Society _gvol. 18 _gno. 11 _gp. 1301-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/mds.10542 _zAvailable from publisher's website |
| 999 |
_c14374717 _d14374717 |
||